首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1606555

日本手術設備市場 - 2024-2031

Japan Surgical Equipments Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

日本手術設備市場2023年達到8.5982億美元，預計到2031年將達到17.2348億美元，2024-2031年預測期間複合年成長率為10.6%。

日本手術設備市場包括各種各樣的設備和儀器，這些設備和儀器對於跨多個醫學專業進行外科手術至關重要。該市場的特點是有幾個關鍵產品類別。手持器械，如鑷子、剪刀、手術刀、牽開器、擴張器、抓緊器和輔助工具，構成了外科手術的支柱。這些儀器對於抓取組織、進行精確切割以及在手術期間提供可視性等任務至關重要。此外，電外科設備透過使用電能切割和凝固組織發揮至關重要的作用，這有助於最大限度地減少失血並提高手術過程中的精確度。

此外，市面上還有專為微創手術設計的腹腔鏡工具。套管針和腹腔鏡等儀器允許外科醫生透過小切口進行手術，從而縮短患者的恢復時間並減少術後疼痛。最後，傷口閉合裝置，包括縫線和吻合器，對於手術後有效閉合切口或傷口、確保正常癒合至關重要。這些不同產品類型的結合凸顯了手術設備市場在促進傳統和微創手術技術、最終改善日本醫療保健系統患者治療效果的重要性。這些因素推動了日本手術設備市場的擴張。

市場動態：

驅動程式和限制

對微創手術的需求不斷成長

對微創手術的需求不斷成長，極大地推動了日本手術設備市場的成長，預計將在整個市場預測期內推動成長。

對微創手術 (MIS) 的需求不斷成長是日本手術設備市場的關鍵驅動力，受到提高患者治療效果和整體醫療效率的多種因素的影響。微創手術的特徵是切口較小，減少了傳統開放性手術帶來的創傷。這種方法可以縮短復健時間、減少術後疼痛並降低併發症風險，從而縮短住院時間，這是優先考慮效率和成本效益的醫療保健系統的重要考慮因素。

根據世界經濟論壇2023年9月發表的文章，目前日本超過10%的人口年齡在80歲以上，而總人口中約33.33%年齡在65歲以上。這一重大的人口變化表明存在大量潛在患者，預計這將增加該國對手術設備的需求。

在日本，人口老化在很大程度上導致了對 MIS 的偏好不斷上升，因為老年人更有可能需要對慢性病進行手術干預。大約 33% 的人口年齡在 65 歲或以上，這對有效但侵入性較小的手術解決方案產生了巨大的需求。此外，機器人輔助系統和增強成像技術等手術技術的進步透過提高手術精度和結果進一步支持了這一趨勢。隨著醫療保健提供者擴大採用這些創新技術，針對微創手術量身定做的專業手術設備的需求預計將會上升，從而推動市場的成長。這種轉變不僅反映了外科手術實踐的不斷發展，而且與更廣泛的醫療保健目標一致，旨在加強患者護理，同時有效管理成本。

此外，產業主要參與者推出的產品將推動日本手術設備市場的成長。例如，2022 年 2 月，全錄輝在日本推出了 CORI 手術系統，標誌著手術器械領域的重大飛躍，特別是膝關節置換術。這項創新產品旨在提高手術準確性並改善患者治療效果，順應微創手術技術日益成長的趨勢。

此外，奧林巴斯公司於2022 年9 月推出了VISERA ELITE III，這是一個尖端的手術可視化平台，專為滿足參與不同醫學學科內視鏡手術的醫療保健專業人員(HCP) 的需求而量身定做。這項創新系統旨在透過將多種先進影像功能整合到一個平台中，增強腹腔鏡結腸切除術和腹腔鏡膽囊切除術等微創手術的能力。

此外，日本國內新興市場需求的不斷成長也有助於日本手術設備市場的擴張。

嚴格的政府法規

嚴格的政府法規是日本手術設備市場的重大限制，影響醫療設備的開發、批准和行銷。監管架構由藥品和醫療器材管理局 (PMDA) 以及厚生勞動省 (MHLW) 管轄，它們執行嚴格的標準，以確保醫療產品在上市前的安全性和有效性。

在日本獲得手術設備批准的途徑非常複雜且耗時。醫療器材依相關風險等級分為四類（I 類至 IV 類），風險較高的器材需要接受更嚴格的評估。例如，對患者風險最高的 IV 類器械在進入市場之前必須通過 PMDA 的全面評估。這種複雜性可能會導致產品發布延遲並增加製造商的成本。

尋求在日本銷售設備的外國公司必須獲得外國製造商註冊 (FMR) 證書。此過程需要全面的文件記錄並遵守當地法規，這對於不熟悉日本監管環境的人來說尤其具有挑戰性。此外，所有提交的文件都必須翻譯成日語，這又增加了一層複雜性。因此，上述因素可能限制日本手術設備市場的潛在成長。

The Japan surgical equipment market includes a wide variety of devices and instruments that are critical for performing surgical procedures across multiple medical specialties. This market is characterized by several key categories of products. Handheld instruments, such as forceps, scissors, scalpels, retractors, dilators, graspers, and auxiliary tools, form the backbone of surgical operations. These instruments are essential for tasks like grasping tissues, making precise cuts, and providing visibility during surgery. Additionally, electrosurgical devices play a vital role by using electrical energy to cut and coagulate tissue, which helps minimize blood loss and enhances precision during procedures.

Furthermore, the market features laparoscopic tools, specifically designed for minimally invasive surgeries. Instruments like trocars and laparoscopes allow surgeons to perform operations through small incisions, leading to quicker recovery times and reduced postoperative pain for patients. Lastly, wound closure devices, including sutures and staplers, are crucial for effectively closing incisions or wounds after surgery, ensuring proper healing. The combination of these diverse product types underscores the importance of the surgical equipment market in facilitating both traditional and minimally invasive surgical techniques, ultimately improving patient outcomes in Japan's healthcare system. These factors have driven Japan surgical equipments market expansion.

Market Dynamics: Drivers & Restraints

Rising Demand for Minimally Invasive Surgical Procedures

The rising demand for minimally invasive surgical procedures is significantly driving the growth of the Japan surgical equipments market and is expected to drive throughout the market forecast period.

The increasing demand for minimally invasive surgical procedures (MIS) is a key driver in the Japan surgical equipment market, influenced by several factors that enhance patient outcomes and overall healthcare efficiency. Minimally invasive surgeries are characterized by smaller incisions, which reduce the trauma associated with traditional open surgeries. This approach leads to quicker recovery times, less postoperative pain, and a lower risk of complications, resulting in shorter hospital stays an essential consideration in a healthcare system that prioritizes efficiency and cost-effectiveness.

According to an article published by the World Economic Forum in September 2023, more than 10% of Japan's population is now aged 80 or older, while approximately 33.33% of the total population is 65 years or older. This significant demographic shift indicates a large potential patient pool, which is expected to drive up the demand for surgical equipment in the country.

In Japan, the aging population significantly contributes to the rising preference for MIS, as older individuals are more likely to require surgical interventions for chronic conditions. Approximately 33% of the population is aged 65 or older, creating a substantial demand for effective yet less invasive surgical solutions. Additionally, advancements in surgical technologies, such as robotic-assisted systems and enhanced imaging techniques, further support this trend by improving precision and outcomes during surgeries. As healthcare providers increasingly adopt these innovative techniques, the demand for specialized surgical equipment tailored for minimally invasive procedures is expected to rise, driving growth in the market. This shift not only reflects evolving surgical practices but also aligns with broader healthcare goals aimed at enhancing patient care while managing costs effectively.

Furthermore, key players in the industry product launches that would drive this Japan surgical equipment market growth. For instance, in February 2022, Smith & Nephew introduced the CORI Surgical System in Japan marking a significant leap forward in the surgical devices sector, especially for knee arthroplasty procedures. This innovative product aims to improve surgical accuracy and enhance patient outcomes, aligning with the increasing trend toward minimally invasive surgical techniques.

Also, in September 2022, Olympus Corporation launched the VISERA ELITE III, a cutting-edge surgical visualization platform tailored to meet the needs of healthcare professionals (HCPs) involved in endoscopic procedures across various medical disciplines. This innovative system is designed to enhance the capabilities of minimally invasive surgeries, such as laparoscopic colectomy and laparoscopic cholecystectomy, by integrating multiple advanced imaging functions into a single platform.

Moreover, the rising demand for emerging markets within Japan contributes to Japan surgical equipment market expansion.

Stringent Government Regulations

Stringent government regulations act as a significant constraint in the Japan surgical equipment market, influencing the development, approval, and marketing of medical devices. The regulatory framework is governed by the Pharmaceutical and Medical Devices Agency (PMDA) and the Ministry of Health, Labor, and Welfare (MHLW), which enforce rigorous standards to ensure the safety and efficacy of medical products before they can be marketed.

The pathway to obtaining approval for surgical equipment in Japan is intricate and can be time-consuming. Medical devices are categorized into four classes based on their associated risk levels (Class I to Class IV), with higher-risk devices undergoing more stringent evaluations. For instance, Class IV devices, which present the highest risk to patients, must pass a thorough assessment by the PMDA before market entry. This complexity can lead to delays in product launches and increased costs for manufacturers.

Foreign companies seeking to sell their devices in Japan must secure a Foreign Manufacturer Registration (FMR) certificate. This process entails comprehensive documentation and compliance with local regulations, which can be particularly challenging for those unfamiliar with Japan's regulatory landscape. Furthermore, all submitted documents must be translated into Japanese, adding another layer of complexity. Thus, the above factors could be limiting the Japan surgical equipments market's potential growth.

Segment Analysis

The Japan surgical equipments market is segmented based on product type, category, application, and end-user.

Product Type:

The wound closure devices segment is expected to dominate the Japan surgical equipments market share

The wound closure devices segment holds a major portion of the Japan surgical equipments market share and is expected to continue to hold a significant portion of the Japan surgical equipments market share during the forecast period.

The wound closure devices segment within the Japanese surgical equipment market is vital for ensuring effective surgical outcomes by properly closing incisions and wounds. This segment primarily consists of surgical sutures and staplers, both of which are crucial for facilitating healing and minimizing complications after surgery.

Surgical sutures are threads used to stitch tissues together following an incision or injury. They are available in various types, including absorbable and non-absorbable materials, enabling surgeons to select the most suitable option based on the specific needs of the procedure and the patient's condition. Sutures are widely utilized across multiple surgical specialties, such as general surgery, orthopedic surgery, and gynecology.

Furthermore, key player's strategies such as partnerships and collaborations would drive this segment growth in the Japan surgical equipments market growth. For instnace, in August 2023, Asensus Surgical, Inc. announced a significant partnership with First Towakai Hospital to lease and utilize its Senhance Surgical System in their urology and gynecology centers, as well as the gastroenterology department. This collaboration highlights the growing trend of integrating advanced robotic surgical systems into healthcare facilities to enhance surgical capabilities and patient outcomes.

Also, in January 2023, MiMedx Group, Inc. announced an exclusive distribution agreement with Gunze Medical Limited, a subsidiary of Gunze Limited, to facilitate the sales of its product EPIFIX in Japan. This partnership is significant as Gunze Medical is a prominent distributor of medical products used in various wound and surgical settings, including bioabsorbable devices and materials such as sutures and sheet products. These factors have solidified the segment's position in the Japan surgical equipments market.

Competitive Landscape

The major players in the Japan surgical equipments market include Olympus, Terumo Corporation, B. Braun SE, Medtronic, CONMED Corporation., Smith+Nephew, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Stryker, and Aspen Surgical Products, Inc. among others.

Key Developments

In September 2024, Olympus Corporation announced the launch of its new 4K camera head, designated CH-S700-08-LB, specifically designed for endoscopic urology and gynecology procedures. This product is compatible with the VISERA ELITE III video system center, which is a comprehensive platform for surgical endoscopy. The camera head will initially be introduced in Europe and is set to launch in Japan, Hong Kong, and Singapore, pending compliance with local regulations.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan surgical equipment's market report delivers a detailed analysis with 40+ key tables, more than 30 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Category & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Category
3.3. Snippet by Application
3.4. Snippet by End-User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Demand for Minimally Invasive Surgical Procedures and
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Government Regulations
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Handheld Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Forceps
- 6.2.4. Scissors
- 6.2.5. Scalpels
- 6.2.6. Retractors
- 6.2.7. Dilators
- 6.2.8. Graspers
- 6.2.9. Auxiliary instruments
6.3. Laparoscopic Devices
- 6.3.1. Trocars and access devices
- 6.3.2. Laparoscopes
6.4. Electrosurgical Devices
6.5. Wound Closure Devices
- 6.5.1. Sutures
- 6.5.2. Staplers
6.6. Others

7. By Category

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
- 7.1.2. Market Attractiveness Index, By Category
7.2. Reusable Surgical Equipment*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Disposable Surgical Equipment

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Gynecology and Urology*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cardiology
8.4. Orthopedics
8.5. Neurology
8.6. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers
9.5. Others

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Olympus*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Terumo Corporation
11.3. B. Braun SE
11.4. Medtronic
11.5. CONMED Corporation.
11.6. Smith+Nephew
11.7. Johnson & Johnson Services, Inc.
11.8. Boston Scientific Corporation
11.9. Stryker
11.10. Aspen Surgical Products, Inc.

LIST NOT EXHAUSTIVE